Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2012
02/09/2012WO2012016706A1 Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one chamomilla plant for the treatment of cancer
02/09/2012WO2012016703A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
02/09/2012WO2012016699A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9'-dihydro-3'h-spiro[cylohexane-1,1'-pyrano[3,4,b]indol]-4-amine
02/09/2012WO2012016698A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain
02/09/2012WO2012016697A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
02/09/2012WO2012016695A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cylohexane-1,1'-pyrano[3,4,b]indol]-4-amine
02/09/2012WO2012016691A1 Use of glyceryl trinitrate for treating traumatic edema
02/09/2012WO2012016690A1 Use of glyceryl trinitrate for treating hematomas
02/09/2012WO2012016683A2 Oral dosage form of pregabalin
02/09/2012WO2012016646A1 Quetiapine tablets
02/09/2012WO2012016619A1 Phenethyl, phenethylene, phenethyne and indanone derivates in cosmetic formulations, especially for use in skin ageing processes
02/09/2012WO2012016569A1 Deuterated tandospirone derivatives as 5-ht1a receptor agonists
02/09/2012WO2012016549A1 Use of salvia miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease
02/09/2012WO2012016510A1 Pyridazine derivatives and use thereof as medicaments for treating microrna viral infection
02/09/2012WO2012016506A1 Crystals of tenofovir disoproxil fumarate
02/09/2012WO2012016487A1 Ptp1b inhibitors, synthesis thereof and application thereof in preparation of medicaments for treating type 2 diabetes mellitus
02/09/2012WO2012016408A1 Pharmaceutical composition for treating hemorrhage caused by blood clotting disorder and use thereof
02/09/2012WO2012016367A1 Trehalose derivatives, preparation methods and uses thereof
02/09/2012WO2012016314A1 Arachidonic acid-derived coxib analogue-substituted compounds for use in treating pain
02/09/2012WO2012004443A8 Phenyl methyl sulfones with anti-inflammatory activity and anti-tumour activity
02/09/2012WO2011156900A3 Compounds, compositions and methods for treatment of multiple sclerosis
02/09/2012WO2011156698A3 NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS
02/09/2012WO2011138328A3 Use of inhibitory molecules for the treatment of pulmonary hypertension
02/09/2012WO2011134944A3 Low-oil pharmaceutical emulsion compositions comprising progestogen
02/09/2012WO2011133637A3 Compounds and methods for kinase modulation, and indications therefor
02/09/2012WO2011130605A9 Compositions and methods for treating pulmonary hypertension
02/09/2012WO2011127232A3 Substituted androst-4-ene diones
02/09/2012WO2011106992A8 Inhibitors of hepatitis c virus ns5b polymerase
02/09/2012WO2011076621A3 Transdermal therapeutic system for administering rivastigmine or derivatives thereof
02/09/2012WO2011062906A8 Treatment of atrial fibrillation
02/09/2012WO2011044503A9 Antibacterial aminoglycoside analogs
02/09/2012WO2011044498A9 Antibacterial aminoglycoside analogs
02/09/2012US20120035409 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
02/09/2012US20120035408 Compounds useful as inhibitors of atr kinase
02/09/2012US20120035407 Compounds useful as inhibitors of atr kinase
02/09/2012US20120035352 6-11 Bicyclic Ketolide Derivatives
02/09/2012US20120035274 Composition for Prevention or Treatment of Obesity, Dyslipidemia, Fatty Liver or Insulin Resistance Syndrome Comprising Camphene as Active Ingredients
02/09/2012US20120035273 Pharmaceutical composition comprising glycerol, white soft paraffin and liquid paraffin for the treatment of uremic xerosis and/or pruritus
02/09/2012US20120035272 Method to Ameliorate Oxidative Stress and Improve Working Memory Via Pterostilbene Administration
02/09/2012US20120035271 Stereoisomers Propofol Therapeutic Compounds
02/09/2012US20120035270 Paediatric solutions comprising a beta-blocker
02/09/2012US20120035269 Cyclopropene amine compounds
02/09/2012US20120035268 Sphingo-guanidines and their use as inhibitors of sphingosine kinase
02/09/2012US20120035267 Paracetamol for parenteral adminstration
02/09/2012US20120035266 Bis(thio-hydrazide amide) salts for treatment of cancers
02/09/2012US20120035265 Compositions, methods, and devices for the treatment of dysmenorrhea
02/09/2012US20120035264 Use of methionine sulfoximine to treat acute liver failure and other diseases caused by an inflammatory cytokine response
02/09/2012US20120035263 Condiment
02/09/2012US20120035262 Compositions and methods for lowering triglycerides
02/09/2012US20120035261 Deuterium-enriched saxagliptin
02/09/2012US20120035260 Tellurium-containing compounds for affecting female's reproductive system following chemotherapy and/or radiotherapy
02/09/2012US20120035259 Controlled Release of Nitric Oxide And Drugs From Functionalized Macromers And Oligomers
02/09/2012US20120035258 Methods of using prodrugs of pregabalin
02/09/2012US20120035257 Histone Deacetylase Inhibitors
02/09/2012US20120035256 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
02/09/2012US20120035255 Derivative of [(3-hydroxy-4 pyron-2-yl)-methyl]-amine and use thereof as anti-neoplastic drugs
02/09/2012US20120035254 Inhibitor for elevation of gip level
02/09/2012US20120035253 Crystalline forms of genistein
02/09/2012US20120035252 Polyphenol-rich extract from plant material
02/09/2012US20120035251 Thiophene inhibitors of ikk-b serine-threonine protein kinase
02/09/2012US20120035250 Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging
02/09/2012US20120035249 Targeted Mucosal Treatment of Obesity and Diabetes
02/09/2012US20120035248 Method for inhibiting the activity of mir-155
02/09/2012US20120035247 RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 6 (STAT6) Gene Expression Using Short Interfering Nucleic Acid (siNA)
02/09/2012US20120035246 Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
02/09/2012US20120035245 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
02/09/2012US20120035244 Parp1 targeted therapy
02/09/2012US20120035243 Dual targeting of mir-208 and mir-499 in the treatment of cardiac disorders
02/09/2012US20120035242 Pharmaceutical composition for treating obesity or diabetes
02/09/2012US20120035241 Use of inhibitors of plac8 activity for the modulation of adipogenesis
02/09/2012US20120035240 Conserved hbv and hcv sequences useful for gene silencing
02/09/2012US20120035239 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
02/09/2012US20120035238 Compounds and methods for treating cancer and viral infections
02/09/2012US20120035237 Pyrazole and triazole carboxamides as crac chann el inhibitors
02/09/2012US20120035235 Methods of treating alpha adrenergic mediated conditions
02/09/2012US20120035234 Composition comprising free amino acids
02/09/2012US20120035233 Medicinal cream made using miconazole nitrate and chitosan and a process to make the same
02/09/2012US20120035232 Use of angiotensin ii agonists
02/09/2012US20120035231 Specific diarylhydantoin and diarylthiohydantoin compounds
02/09/2012US20120035230 Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies
02/09/2012US20120035227 Deuterium-enriched ixabepilone
02/09/2012US20120035226 Oxadiazole derivatives
02/09/2012US20120035225 Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
02/09/2012US20120035222 Solid forms of 2-Chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine
02/09/2012US20120035219 Compound for the Treatment of Tuberculosis
02/09/2012US20120035217 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
02/09/2012US20120035216 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
02/09/2012US20120035215 Method of predicting a predisposition to qt prolongation
02/09/2012US20120035214 Renin inhibitors
02/09/2012US20120035213 Quinoline derivative
02/09/2012US20120035212 (L)-Malate salt of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
02/09/2012US20120035211 Novel polymorphs of saquinavir
02/09/2012US20120035210 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases
02/09/2012US20120035209 Hydroxy Substituted 1H-Imidazopyridines and Methods
02/09/2012US20120035208 Pyrazolopyridine pi3k inhibitor compounds and methods of use
02/09/2012US20120035207 Use of GABAA Receptor Agonists for the Treatment of Hearing, Vestibular and Attention Disorders, Intention Tremor and Restless Leg Syndrome
02/09/2012US20120035206 Preparation and application of novel antibacterial and anticancer compounds and their derivatives
02/09/2012US20120035205 Treatment for basal cell carcinoma
02/09/2012US20120035204 Methods for Treating Obesity and Disorders Associated with Hyperlipidemia in a Mammal
02/09/2012US20120035203 Butaclamol for the treatment of amyotrophic lateral sclerosis
1 ... 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 ... 7860